Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
中國抗體中國區總裁離任

2025-06-08T  
中國抗體折讓11.29%發新股 籌淨額1.24億元

2025-05-14T  
中國抗體SM17治療特異性皮炎臨床試驗積極頂線結果

2025-04-08T  
《業績》中國抗體全年虧損收窄至1.85億人民幣

2025-03-31T  
中國抗體SM17中國1b期臨床試驗完成全部患者入組

2024-12-09T  
《業績》中國抗體-B中期虧損收窄至9,062萬人民幣

2024-08-20T  
中國抗體全新抗體SM17完成首例患者給藥

2024-06-12T  
《公司業績》中國抗體全年虧損收窄至2.43億人民幣

2024-03-26T  
中國抗體折讓18%發新股 籌淨額7,318萬元

2023-12-15T  
中國抗體SM17臨床試驗完成首例受試者給藥

2023-11-28T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.